Simparica Trio (Sarolaner, Moxidectin, Pyrantel)
Monthly Simparica Trio prevents heartworm disease, kills adult fleas and is indicated for the treatment and prevention of flea infestations, the treatment and control of tick infestations, and the treatment and control of roundworm and adult hookworm infections in dogs and puppies 8 weeks of age and older, and weighing 2.8 pounds or greater.
DOSAGE AND ADMINISTRATION SIMPARICA TRIO is given orally once a month, at the recommended minimum dose of 0.54 mg/lb (1.2 mg/kg) sarolaner, 0.011 mg/lb (24 µg/kg) moxidectin, and 2.27 mg/lb (5 mg/kg) pyrantel (as pamoate salt).
•Sarolaner was first approved by the FDA in 2016 to treat and control flea and tick infestations. •Moxidectin was first approved by the FDA in 1997 for the prevention of heartworm disease in dogs. •Pyrantel Pamoate was first approved in 1977 for the treatment and control of adult roundworms and adult hookworms in dogs.
ADVERSE REACTIONS In a field safety and effectiveness study, SIMPARICA TRIO was administered to dogs for the prevention of heartworm disease. The study included a total of 410 dogs treated once monthly for 11 treatments (272 treated with SIMPARICA TRIO and 138 treated with an active control). Over the 330-day study period, all observations of potential adverse reactions were recorded.
Product Code : 13690
Subscribe & Save
Don't miss out on the exclusive deals we have to offer!